Holm Schneider, MD

Holm Schneider obtained his MD from the University of Leipzig and received German board certifications in general pediatrics, emergency medicine and neonatology. He was research fellow at Imperial College London, U.K., registrar at the University Hospital Erlangen, Germany, and Professor of Experimental Neonatology at Innsbruck Medical University, Austria, before returning to the University Hospital Erlangen where he has been working as Professor of Pediatrics since 2008. He is head of the interdisciplinary Center for Ectodermal Dysplasias Erlangen, the German national reference center for ectodermal dysplasias and p63-associated disorders. The research of his team is dedicated to novel therapeutic approaches to severe genodermatoses. Schneider pioneered the prenatal drug therapy of genetic diseases and conducted numerous preclinical and investigator-initiated or industry-funded clinical studies on life-threatening congenital disorders. He received prestigious honors and awards, including the Gottron-Just Science Prize, the Gold medal of the Union of European Neonatal and Perinatal Societies, and the Care-for-Rare Science Award.